Mac Johnson

Mac Johnson possesses extensive experience in the pharmaceutical industry, currently serving as Vice President of Research at Vertex Pharmaceuticals since 2006, where responsibilities include leading Exploratory Research and the Disease Strategy Team for Alpha-1 Antitrypsin Deficiency. Previously held roles at Vertex include Executive Director and Senior Director of Research, with a focus on early project incubation and integrated biology. Prior to Vertex, Mac worked at Millennium Pharmaceuticals and Eli Lilly and Company, contributing to imaging sciences and molecular imaging initiatives. Educational qualifications include an MBA from MIT Sloan School of Management and a PhD in Molecular and Cellular Biology from Baylor College of Medicine, complemented by a BS in Biology from The University of Georgia.